Related Experiment Video
Updated: Apr 7, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Novel protein-protein interactions of TPPII, p53, and SIRT7
1Department of Medical Biochemistry and Microbiology (IMBIM), BMC, Uppsala University, Box 582, 751 23, Uppsala, Sweden. jarmila.nahalkova@gmail.com.
Abstract:
Novel protein-protein interactions of TPPII, SIRT7, and p53 were detected by co-immunoprecipitation using both HeLa cell lysates and the cytoplasmic fraction prepared by fractionation of mouse liver tissue. The interactions were further verified in vivo by in situ proximity ligation assay (PLA) within control HEK293 cells transformed with empty vector, highactTPPII HEK293 cells over-expressing murine TPPII displaying high specific enzymatic activity and in lowactTPPII HEK293 cells over-expressing human TPPII having low specific activity of the enzyme. Besides an abundant cytoplasmic localization of TPPII-p53 interaction signal, the nuclear interactions were also demonstrated. The cytoplasmic interactions were likewise detected between TPPII and SIRT7 in control HEK293 and lowactTPPII HEK293 cells. The interactions of SIRT7 with p53 were confirmed in three HEK293 cell transformants as well. The cytoplasmic occurrence of SIRT7 protein was demonstrated by immunofluorescence, when both nucleolar and cytoplasmic signals were identified within HEK293 cells and primary human fibroblasts. The unique cytoplasmic localization of SIRT7 protein was discussed based on an epitope specificity of N-terminus specific SIRT7 antibodies utilized in the present study compared with C-terminus specific antibodies previously used for nuclear detection of SIRT7 by other authors. The epitope sequence of N-terminal antibodies is occurring in all three splicing variants of SIRT7 compared to the epitope of C-terminal antibody, which is specific exclusively to the splicing variant 1. The cytoplasmic localization of p53 detected by immunofluorescence supported the results from its interactions with TPPII and SIRT7 observed by in situ PLA within model cells. Novel interactions of TPPII, p53, and SIRT7 presented in this study might contribute to the knowledge of the regulatory effects of these proteins on apoptotic pathways and to the understanding mechanisms of aging and lifespan regulation.
Insights
Novel interactions between TPPII, SIRT7, and p53 proteins were identified, revealing their roles in cellular pathways. These findings shed light on aging and lifespan regulation mechanisms.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- The proteins TPPII, SIRT7, and p53 are implicated in various cellular processes, including apoptosis.
- Understanding their interactions is crucial for elucidating regulatory mechanisms in aging and lifespan.
Purpose of the Study:
- To identify and characterize novel protein-protein interactions among TPPII, SIRT7, and p53.
- To investigate the cellular localization of these interactions and the involved proteins.
Main Methods:
- Co-immunoprecipitation assays using HeLa cell lysates and mouse liver fractions.
- In situ proximity ligation assay (PLA) in engineered HEK293 cells.
- Immunofluorescence microscopy to confirm protein localization.
Main Results:
- Novel interactions between TPPII, SIRT7, and p53 were confirmed in vitro and in vivo.
- Both cytoplasmic and nuclear localization of TPPII-p53 interactions were observed.
- Cytoplasmic localization of TPPII-SIRT7 and SIRT7-p53 interactions were detected.
- Cytoplasmic presence of SIRT7 was demonstrated, potentially due to N-terminus specific antibodies.
Conclusions:
- The identified interactions of TPPII, SIRT7, and p53 contribute to understanding their roles in apoptotic pathways.
- These findings advance the knowledge of mechanisms regulating aging and lifespan.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Protein-protein Interfaces
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway

